LIVANOVA PLC (LIVN) Fundamental Analysis & Valuation

NASDAQ:LIVN • GB00BYMT0J19

Current stock price

60.1 USD
+1.18 (+2%)
At close:
60.1 USD
0 (0%)
After Hours:

This LIVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. LIVN Profitability Analysis

1.1 Basic Checks

  • In the past year LIVN was profitable.
  • LIVN had a positive operating cash flow in the past year.
  • In multiple years LIVN reported negative net income over the last 5 years.
  • LIVN had a positive operating cash flow in each of the past 5 years.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • The Return On Assets of LIVN (-9.30%) is better than 62.03% of its industry peers.
  • LIVN has a Return On Equity (-20.21%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of LIVN (8.12%) is better than 83.96% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LIVN is below the industry average of 9.12%.
  • The last Return On Invested Capital (8.12%) for LIVN is above the 3 year average (5.19%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROIC 8.12%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 14.69%, LIVN belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LIVN has grown nicely.
  • Looking at the Gross Margin, with a value of 68.04%, LIVN is in the better half of the industry, outperforming 73.80% of the companies in the same industry.
  • LIVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.69%
PM (TTM) N/A
GM 68.04%
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. LIVN Health Analysis

2.1 Basic Checks

  • LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • LIVN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LIVN has more shares outstanding
  • The debt/assets ratio for LIVN has been reduced compared to a year ago.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • LIVN has an Altman-Z score of 1.69. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
  • LIVN has a Altman-Z score of 1.69. This is comparable to the rest of the industry: LIVN outperforms 54.01% of its industry peers.
  • The Debt to FCF ratio of LIVN is 2.17, which is a good value as it means it would take LIVN, 2.17 years of fcf income to pay off all of its debts.
  • LIVN has a Debt to FCF ratio of 2.17. This is amongst the best in the industry. LIVN outperforms 85.03% of its industry peers.
  • LIVN has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.29, LIVN is in line with its industry, outperforming 52.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Altman-Z 1.69
ROIC/WACC0.94
WACC8.67%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that LIVN should not have too much problems paying its short term obligations.
  • LIVN's Current ratio of 1.36 is on the low side compared to the rest of the industry. LIVN is outperformed by 82.35% of its industry peers.
  • A Quick Ratio of 1.16 indicates that LIVN should not have too much problems paying its short term obligations.
  • LIVN has a Quick ratio of 1.16. This is in the lower half of the industry: LIVN underperforms 74.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.16
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LIVN Growth Analysis

3.1 Past

  • LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.73%, which is quite good.
  • The Earnings Per Share has been growing by 25.16% on average over the past years. This is a very strong growth
  • Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 10.74% in the last year.
  • Measured over the past years, LIVN shows a quite strong growth in Revenue. The Revenue has been growing by 8.24% on average per year.
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%

3.2 Future

  • LIVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.89% yearly.
  • Based on estimates for the next years, LIVN will show a small growth in Revenue. The Revenue will grow by 6.16% on average per year.
EPS Next Y10.08%
EPS Next 2Y9.39%
EPS Next 3Y10.01%
EPS Next 5Y10.89%
Revenue Next Year8.32%
Revenue Next 2Y7.47%
Revenue Next 3Y7.5%
Revenue Next 5Y6.16%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. LIVN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.41, which indicates a correct valuation of LIVN.
  • Compared to the rest of the industry, the Price/Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 84.49% of the companies listed in the same industry.
  • LIVN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.54.
  • With a Price/Forward Earnings ratio of 14.00, LIVN is valued correctly.
  • 88.24% of the companies in the same industry are more expensive than LIVN, based on the Price/Forward Earnings ratio.
  • LIVN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.68.
Industry RankSector Rank
PE 15.41
Fwd PE 14
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaper than 86.10% of the companies in the same industry.
  • 89.30% of the companies in the same industry are more expensive than LIVN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.97
EV/EBITDA 11.84
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.53
PEG (5Y)0.61
EPS Next 2Y9.39%
EPS Next 3Y10.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LIVN Dividend Analysis

5.1 Amount

  • No dividends for LIVN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVN Fundamentals: All Metrics, Ratios and Statistics

LIVANOVA PLC

NASDAQ:LIVN (4/30/2026, 4:30:03 PM)

After market: 60.1 0 (0%)

60.1

+1.18 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners106.98%
Inst Owner Change2.51%
Ins Owners0.36%
Ins Owner Change6.74%
Market Cap3.29B
Revenue(TTM)1.39B
Net Income(TTM)-242.47M
Analysts82.35
Price Target79.96 (33.04%)
Short Float %5.86%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.93%
Min EPS beat(2)3.44%
Max EPS beat(2)18.42%
EPS beat(4)4
Avg EPS beat(4)13.83%
Min EPS beat(4)3.44%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)17.63%
EPS beat(12)11
Avg EPS beat(12)17.8%
EPS beat(16)14
Avg EPS beat(16)14%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.14%
Max Revenue beat(2)2.12%
Revenue beat(4)4
Avg Revenue beat(4)2.26%
Min Revenue beat(4)0.14%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.08%
Revenue beat(12)11
Avg Revenue beat(12)3.31%
Revenue beat(16)14
Avg Revenue beat(16)2.76%
PT rev (1m)9.25%
PT rev (3m)9.53%
EPS NQ rev (1m)0.67%
EPS NQ rev (3m)-0.44%
EPS NY rev (1m)0.21%
EPS NY rev (3m)1.83%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)2.05%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 15.41
Fwd PE 14
P/S 2.37
P/FCF 18.97
P/OCF 12.92
P/B 2.74
P/tB 18.55
EV/EBITDA 11.84
EPS(TTM)3.9
EY6.49%
EPS(NY)4.29
Fwd EY7.14%
FCF(TTM)3.17
FCFY5.27%
OCF(TTM)4.65
OCFY7.74%
SpS25.38
BVpS21.94
TBVpS3.24
PEG (NY)1.53
PEG (5Y)0.61
Graham Number43.8791 (-26.99%)
Profitability
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROCE 11.34%
ROIC 8.12%
ROICexc 12.57%
ROICexgc 104.62%
OM 14.69%
PM (TTM) N/A
GM 68.04%
FCFM 12.48%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
ROICexc(3y)7.23%
ROICexc(5y)5.51%
ROICexgc(3y)42.15%
ROICexgc(5y)N/A
ROCE(3y)7.24%
ROCE(5y)5.79%
ROICexgc growth 3Y126.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.54%
ROICexc growth 5YN/A
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Debt/EBITDA 1.38
Cap/Depr 175.19%
Cap/Sales 5.84%
Interest Coverage 6.56
Cash Conversion 101.65%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.16
Altman-Z 1.69
F-Score5
WACC8.67%
ROIC/WACC0.94
Cap/Depr(3y)118.73%
Cap/Depr(5y)92.37%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
EPS Next Y10.08%
EPS Next 2Y9.39%
EPS Next 3Y10.01%
EPS Next 5Y10.89%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%
Revenue Next Year8.32%
Revenue Next 2Y7.47%
Revenue Next 3Y7.5%
Revenue Next 5Y6.16%
EBIT growth 1Y25.59%
EBIT growth 3Y35.73%
EBIT growth 5YN/A
EBIT Next Year27.32%
EBIT Next 3Y16.46%
EBIT Next 5Y-0.2%
FCF growth 1Y27.48%
FCF growth 3Y58.64%
FCF growth 5YN/A
OCF growth 1Y38.95%
OCF growth 3Y53.79%
OCF growth 5YN/A

LIVANOVA PLC / LIVN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


Can you provide the profitability details for LIVANOVA PLC?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What are the PE and PB ratios of LIVANOVA PLC (LIVN) stock?

The Price/Earnings (PE) ratio for LIVANOVA PLC (LIVN) is 15.41 and the Price/Book (PB) ratio is 2.74.


How financially healthy is LIVANOVA PLC?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.